Yes, staph bacteria can cause meningitis, and when they do, the infection tends to be more dangerous than many other forms. Staphylococcal meningitis accounts for about 3% of all meningitis-related hospitalizations in the United States, making it less common than viral or streptococcal meningitis but still a serious concern. It most often occurs in people who have had brain or spinal surgery, carry implanted devices like cerebrospinal fluid shunts, or have a staph infection elsewhere in the body that spreads to the brain.
How Staph Bacteria Reach the Brain
Staph doesn’t typically start as a brain infection. It reaches the central nervous system through one of two main routes. The first is direct spread from a nearby infection, such as a skin infection on the face or scalp, an abscess near the skull or spine, or contamination during surgery. The second is through the bloodstream: when a staph infection somewhere else in the body, like the heart valves or a wound, enters the blood and seeds the membranes surrounding the brain. This blood-borne route is especially common in people with staphylococcal bloodstream infections.
Two species are primarily responsible. Staphylococcus aureus, the more aggressive of the two, typically causes meningitis by spreading through the bloodstream from infections like endocarditis (an infection of the heart valves). Staphylococcus epidermidis, a normally harmless skin bacterium, is a leading cause of infections on implanted hardware like cerebrospinal fluid shunts. These shunt infections typically develop anywhere from 15 days to 12 months after surgery, and coagulase-negative staphylococci like S. epidermidis cause 17 to 78% of them depending on the medical center.
Who Is Most at Risk
Staph meningitis is overwhelmingly a healthcare-associated infection. The people most likely to develop it include:
- Neurosurgery patients, particularly those with cerebrospinal fluid shunts, drains, or recent brain or spinal procedures
- People with staph bloodstream infections, especially from endocarditis or infected intravenous lines
- People who use intravenous drugs, which increases the risk of both bloodstream staph infections and endocarditis
- People with head trauma, including skull fractures that create a pathway for bacteria
- Immunocompromised individuals, whose bodies are less able to contain staph infections before they spread
A healthy person with no surgical history or underlying staph infection has a very low chance of developing staphylococcal meningitis. This is not the type of meningitis that typically spreads through college dormitories or close contact. It almost always requires a predisposing condition.
Symptoms to Recognize
Staphylococcal meningitis produces the classic symptoms of bacterial meningitis, and they can come on quickly. The hallmarks are severe headache, stiff neck, high fever with chills, and sensitivity to light. Nausea, vomiting, and changes in mental status, ranging from confusion to decreased alertness, are also common.
In infants and young children, the signs look different. A bulging soft spot on the head, poor feeding, irritability, and rapid breathing may be the main clues. Some infants adopt an unusual posture with the head and neck arched backward.
One feature that can help distinguish staph meningitis from other bacterial causes is context. If someone develops these symptoms after recent neurosurgery, while hospitalized with a known staph infection, or while being treated for endocarditis, staph should be high on the list of suspected causes. In one published case, a patient initially suspected of having meningococcal meningitis turned out to have staphylococcal endocarditis that had spread to the brain, highlighting how important it is for clinicians to look for the underlying source of infection.
How It Is Diagnosed
Diagnosis requires a lumbar puncture, commonly called a spinal tap. A sample of cerebrospinal fluid is drawn and analyzed. In bacterial meningitis, including the staph variety, the fluid typically shows a high white blood cell count (predominantly a type called neutrophils), elevated protein levels, and low glucose, often less than 50% of the blood glucose level measured at the same time. The fluid is also cultured to identify the specific bacterium and determine which antibiotics will work against it.
In people with severely weakened immune systems, these typical changes in the spinal fluid may be less pronounced, which can make the diagnosis harder to catch early.
Treatment and What to Expect
Staph meningitis requires intravenous antibiotics, and the choice depends on whether the strain is resistant to common drugs. For methicillin-resistant strains (MRSA), vancomycin is the standard treatment. When lab results confirm the strain is susceptible to standard antibiotics, the treatment can be switched accordingly. In cases involving infected shunts or other hardware, the device often needs to be removed to clear the infection completely.
Treatment typically requires a hospital stay, often in an intensive care unit for the initial phase. The length of the antibiotic course depends on the severity of infection and whether complications develop. If the meningitis originated from endocarditis or another deep-seated infection, that source needs to be treated as well, which can extend the overall treatment timeline significantly.
Mortality and Long-Term Outlook
Staphylococcal meningitis carries a higher risk of death than many other bacterial causes. A large Japanese study covering hospitalizations from 2016 to 2022 found that bacterial meningitis overall had a mortality rate of about 9.5%, but Staphylococcus aureus as the causative organism was an independent risk factor that raised the odds of death by roughly 71% compared to other bacterial causes. Older age and male sex were also associated with worse outcomes.
Among survivors, neurological aftereffects are a real concern. Brain abscesses, inflammation of the brain’s fluid-filled cavities, and blood clots in the veins around the brain can all complicate staph meningitis. The U.S. hospitalization data from AHRQ showed that staphylococcal meningitis had an average hospital cost of $54,500 per stay and kept patients hospitalized for an average of about 42 days, reflecting the severity and complexity of these cases. Over half of patients were transferred to other care facilities after discharge rather than going home, suggesting many needed ongoing rehabilitation or monitoring.
The prognosis improves considerably when the infection is caught early, the right antibiotics are started quickly, and the underlying source of staph is identified and controlled. Shunt-related infections caused by S. epidermidis generally have better outcomes than bloodstream-spread S. aureus meningitis, partly because S. epidermidis is a less aggressive organism.